Physician profile
Hakan Paydak
NPI 1871547828
$2,432.48
in general payments reported to CMS, 2019-2025
10 companies · $338 in 2025
The $338 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,154 · 2020: $105 · 2022: $183 · 2023: $320 · 2024: $332 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $990.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,606.16 | 2019-2025 | Mitraclip, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Medtronic, INC. | $376.61 | 2022-2025 | Aurora Ev-Icd Mri Surescan, Micra, Dxterity |
| Boston Scientific Corporation | $320.60 | 2020-2025 | Emblem Mri S-Icd, Watchman Flx |
| Biotronik INC. | $27.67 | 2019 | |
| Philips North America LLC | $23.45 | 2025 | Lm Undivided |
| Cardiva Medical, INC. | $18.14 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Shockwave Medical, INC | $17.93 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $15.52 | 2025 | Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $14.28 | 2019 | |
| Biosense Webster, INC. | $12.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hakan Paydak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.